NUTRA PHARMA CORP Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Nutra Pharma Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2022.
  • Nutra Pharma Corp Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $43.4K, a 61.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $43.4K -$68.7K -61.3% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 $58.9K -$77.7K -56.9% Jun 30, 2022 10-Q 2022-08-22
Q1 2022 $75K -$72.7K -49.2% Mar 31, 2022 10-Q 2022-05-20
Q4 2021 $93.8K -$50.2K -34.9% Dec 31, 2021 10-Q 2022-11-21
Q3 2021 $112K -$33.5K -23% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $137K -$31.6K -18.8% Jun 30, 2021 10-Q 2021-09-24
Q1 2021 $148K -$52.6K -26.3% Mar 31, 2021 10-Q 2021-09-17
Q4 2020 $144K -$63.5K -30.6% Dec 31, 2020 10-K 2022-04-15
Q3 2020 $146K -$74.9K -34% Sep 30, 2020 10-Q 2021-08-12
Q2 2020 $168K -$83.7K -33.2% Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $200K -$65.7K -24.7% Mar 31, 2020 10-Q 2021-07-23
Q4 2019 $208K -$73.6K -26.2% Dec 31, 2019 10-K 2021-09-08
Q3 2019 $221K Sep 30, 2019 10-Q 2021-05-14
Q2 2019 $252K Jun 30, 2019 10-Q 2021-05-07
Q1 2019 $266K Mar 31, 2019 10-Q 2021-04-05
Q4 2018 $281K Jan 2, 2019 10-K 2021-07-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.